April 24, 2018 2:48 PM ET

Pharmaceuticals

Company Overview of Quark Pharmaceuticals, Inc.

Key Executives for Quark Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Daniel Zurr Ph.D.20 RelationshipsFounder, Chief Executive Officer, President and Director 71
Tomer Natan LLM, BB, CPANo RelationshipsChief Financial Officer--
Rami Skaliter Ph.D.3 RelationshipsChief Operating Officer59
Shai S. Erlich Ph.D.No RelationshipsChief Medical Officer51
Juliana Friedmann M.Sc.No RelationshipsSenior Vice President of Strategy & Planning65

Quark Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Philip B. Simon J.D., CPA 20 RelationshipsLawrence Investments, LLC64
Daniel Zurr Ph.D. 20 RelationshipsQuark Pharmaceuticals, Inc.71
Philip M. Hahn 20 RelationshipsQuark Pharmaceuticals, Inc.75
André G. Pernet Ph.D., M.B.A 20 RelationshipsGenset Corporation72
Dov Weinberger M.D. 20 RelationshipsQuark Pharmaceuticals, Inc.--
View All Board Members

Quark Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee J.D., CPAPhilip B. Simon20 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$322.3K
322.3K
328.0K
Bonus$135.0K
135.0K
276.6K
Total Short Term Compensation
Not meaningful
Total Value of Options$457.3K
457.3K
9.3M
Compensation as of Fiscal Year 2010
Quark Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Lannett Names Maureen Cavanaugh as Senior Vice President and Chief Commercial Operations Officer
April 20, 2018 10:53 AM ET
Sihuan Pharmaceutical Holdings Group Ltd. Announces Board Changes
April 20, 2018 9:53 AM ET
Vectura Group plc Announces Resignation of Andrew Derodra as Chief Financial Officer and Executive Director
April 20, 2018 6:00 AM ET
Terra Tech Corp Announces Termination of Kenneth Vande Vrede as Chief Agricultural Officer
April 19, 2018 8:30 PM ET
Dermira, Inc. Appoints Christopher Horan as Chief Technical Operations Officer
April 19, 2018 8:04 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Quark Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.